Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Jaguar Health, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q4 2023
- Shares held
- 5.83M
- +4.59M (+372.4%) vs. Q4 2023
- Total value
- $523.7K
- +$339.4K (+184.1%) vs. Q4 2023
- New holders
- 7
- 6 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 2,595,782 | $233.4K | 0.00% | +2,544,627+4,974.3% | Added |
| Commonwealth Equity Services, LLC | 899,170 | $81.0K | 0.00% | +873,293+3,374.8% | Added |
| Jane Street Group, LLC | 798,485 | $71.8K | 0.00% | +781,925+4,721.8% | Added |
| XTX Topco Ltd | 450,634 | $40.5K | 0.01% | +450,634 | New |
| Bank of America Corp | 242,404 | $21.6K | 0.00% | +242,404 | New |
| Vanguard Group Inc | 192,335 | $17.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 157,303 | $14.1K | 0.00% | +157,303 | New |
| Geode Capital Management, LLC | 127,671 | $11.5K | 0.00% | −1,745−1.3% | Reduced |
| Csenge Advisory Group | 102,500 | $9.21K | 0.00% | +25,000+32.3% | Added |
| Focused Wealth Management, Inc | 74,077 | $6.66K | 0.00% | +74,077 | New |
| Tower Research Capital LLC (TRC) | 59,328 | $5.34K | 0.00% | +59,328 | New |
| Boothbay Fund Management, LLC | 49,773 | $4.47K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 43,506 | $3.92K | 0.00% | +6,351+17.1% | Added |
| Two Sigma Investments, LP | 26,026 | $2.34K | 0.00% | +26,026 | New |
| ICA Group Wealth Management, LLC | 4,500 | $405 | 0.00% | +4,500 | New |
| Morgan Stanley | 1,679 | $151 | 0.00% | −44,707−96.4% | Reduced |
| Group One Trading, L.P. | 737 | $66 | 0.00% | −9−1.2% | Reduced |
| Wells Fargo & Company | 373 | $34 | 0.00% | +251+205.7% | Added |
| JPMorgan Chase & Co | 2 | $0 | 0.00% | −163,669−100.0% | Reduced |
| Royal Bank of Canada | 1 | $0 | 0.00% | −521−99.8% | Reduced |
| FMR LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −193,330−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −100,684−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −62,255−100.0% | Sold out |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −35,538−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,330−100.0% | Sold out |